These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 17144532)

  • 21. 9p21 index as estimated by dual-color fluorescence in situ hybridization is useful to predict urothelial carcinoma recurrence in bladder washing cytology.
    Kawauchi S; Sakai H; Ikemoto K; Eguchi S; Nakao M; Takihara H; Shimabukuro T; Furuya T; Oga A; Matsuyama H; Takahashi M; Sasaki K
    Hum Pathol; 2009 Dec; 40(12):1783-9. PubMed ID: 19733894
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical utility of fluorescent in situ hybridization for the surveillance of bladder cancer patients treated with bacillus Calmette-Guérin therapy.
    Mengual L; Marín-Aguilera M; Ribal MJ; Burset M; Villavicencio H; Oliver A; Alcaraz A
    Eur Urol; 2007 Sep; 52(3):752-9. PubMed ID: 17379395
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular cytogenetic characterization and diagnostics of bladder cancer.
    Houskova L; Zemanova Z; Babjuk M; Melichercikova J; Pesl M; Michalova K
    Neoplasma; 2007; 54(6):511-6. PubMed ID: 17949235
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular genetic methods in the diagnosis of invasive bladder cancer.
    Krause FS; Feil G; Zumbrägel A; Bichler KH
    Anticancer Res; 2000; 20(6D):5015-21. PubMed ID: 11326660
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Urinary fluorescence in situ hybridization assay for detecting urothelial carcinoma in Taiwanese patients.
    Chuang KL; Chuang HC; Ng KF; Chang YH; Wu CT; Chuang CK; Liao SK; Pang ST
    BJU Int; 2010 May; 105(10):1413-6. PubMed ID: 19818076
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Aneusomy for detection of bladder cancer recurrence: a Southwest Oncology Group study.
    Wolman SR; Goldman B; Slovak ML; Tangen C; Persons DL; Wood D
    Cancer Genet Cytogenet; 2007 Jul; 176(1):22-7. PubMed ID: 17574960
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Should we abandon the FISH test?
    Nieder AM; Soloway MS; Herr HW
    Eur Urol; 2007 Jun; 51(6):1469-71. PubMed ID: 17257740
    [No Abstract]   [Full Text] [Related]  

  • 28. Fluorescence in situ hybridization for detecting transitional cell carcinoma: implications for clinical practice.
    Laudadio J; Keane TE; Reeves HM; Savage SJ; Hoda RS; Lage JM; Wolff DJ
    BJU Int; 2005 Dec; 96(9):1280-5. PubMed ID: 16287445
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multicolor fluorescence in situ hybridization (M-FISH) on cells from urine for the detection of bladder cancer.
    Junker K; Fritsch T; Hartmann A; Schulze W; Schubert J
    Cytogenet Genome Res; 2006; 114(3-4):279-83. PubMed ID: 16954667
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interphase cytogenetic studies of bladder cancer.
    Wang MR; Perissel B; Taillandier J; Malet P
    Bull Cancer; 1994 Dec; 81(12):1060-6. PubMed ID: 7742594
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Automated quantification of FISH signals in urinary cells enables the assessment of chromosomal aberration patterns characteristic for bladder cancer.
    Köhler CU; Martin L; Bonberg N; Behrens T; Deix T; Braun K; Noldus J; Jöckel KH; Erbel R; Sommerer F; Tannapfel A; Harth V; Käfferlein HU; Brüning T
    Biochem Biophys Res Commun; 2014 Jun; 448(4):467-72. PubMed ID: 24802410
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fluorescence in situ hybridization detects frequent chromosome 9 deletions and aneuploidy in histologically normal urothelium of bladder cancer patients.
    Obermann EC; Meyer S; Hellge D; Zaak D; Filbeck T; Stoehr R; Hofstaedter F; Hartmann A; Knuechel R
    Oncol Rep; 2004 Apr; 11(4):745-51. PubMed ID: 15010867
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recurrence and progression in patients with non-muscle invasive bladder cancer: prognostic models including multicolor fluorescence in situ hybridization molecular grading.
    Lodde M; Mian C; Mayr R; Comploj E; Trenti E; Melotti R; Campodonico F; Maffezzini M; Fritsche HM; Pycha A
    Int J Urol; 2014 Oct; 21(10):968-72. PubMed ID: 24947145
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of polysomy 17 in transitional cell carcinoma of the bladder: immunohistochemical study of HER2/neu expression and fish analysis of c-erbB-2 gene and chromosome 17.
    Simonetti S; Russo R; Ciancia G; Altieri V; De Rosa G; Insabato L
    Int J Surg Pathol; 2009 Jun; 17(3):198-205. PubMed ID: 19443884
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Patterns of chromosomal aberrations in urinary bladder tumours and adjacent urothelium.
    Steidl C; Simon R; Bürger H; Brinkschmidt C; Hertle L; Böcker W; Terpe HJ
    J Pathol; 2002 Sep; 198(1):115-20. PubMed ID: 12210071
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Specific chromosome aberrations in peripheral blood lymphocytes are associated with risk of bladder cancer.
    Shao L; Lerner SL; Bondaruk J; Czerniak BA; Zeng X; Grossman HB; Spitz MR; Wu X
    Genes Chromosomes Cancer; 2004 Dec; 41(4):379-89. PubMed ID: 15390184
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Novel recurrent structural chromosomal aberrations in primary bladder cancer.
    Panani AD; Ferti AD; Raptis SA; Roussos C
    Anticancer Res; 2004; 24(5A):2967-74. PubMed ID: 15517903
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chromosomal alterations detected by fluorescence in situ hybridization in urothelial carcinoma and rarer histologic variants of bladder cancer.
    Kipp BR; Tyner HL; Campion MB; Voss JS; Karnes RJ; Sebo TJ; Halling KC; Zhang J
    Am J Clin Pathol; 2008 Oct; 130(4):552-9. PubMed ID: 18794047
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prospective evaluation of the clinical usefulness of reflex fluorescence in situ hybridization assay in patients with atypical cytology for the detection of urothelial carcinoma of the bladder.
    Lotan Y; Bensalah K; Ruddell T; Shariat SF; Sagalowsky AI; Ashfaq R
    J Urol; 2008 Jun; 179(6):2164-9. PubMed ID: 18423745
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chromosomal aberrations in Cis and Ta bilharzial bladder cancer: a theory of pathogenesis.
    Khaled HM; Aly MS; Mokhtar N
    Urol Oncol; 2004; 22(6):443-7. PubMed ID: 15610858
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.